Christopher B. Ehrlich, Director, 10% Owner at Transcept Pharmaceuticals Inc (TSPT), bought 732,076 shares at $7.24 ($5.0M) on 2011-09-21, disclosed to the SEC on 2011-09-22.
Open-market purchase of $5.0M TSPT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 514,848 | $3.4M | 68.3% |
| 2 | $7.24 | 217,228 | $1.6M | 31.7% |
| Total | $6.78 avg | 732,076 | $5.0M | 100% |
| Filing → |
| EFTR | BUY | 2022-02-22 | $13K | — | Filing → |
| EFTR | BUY | 2022-02-10 | $10K | — | Filing → |
| EFTR | BUY | 2022-02-07 | $31K | — | Filing → |